ARCHIVES

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

This article is from The Cancer Letter archive.

Vol. 22 No. 46 | November 29, 1996

Download PDF Visit The Full Archive

Related Articles

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984